As of 2024-12-12, the Relative Valuation of Regenxbio Inc (RGNX) is (133.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.30 USD, the upside of Regenxbio Inc based on Relative Valuation is -1530.3%.
The range of the Relative Valuation is (135.62) - (150.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.1x - 44.9x | 34.7x |
| Forward P/E multiples | 19.8x - 31.3x | 20.5x |
| Fair Price | (135.62) - (150.66) | (133.02) |
| Upside | -1558.3% - -1720.0% | -1530.3% |
| Date | P/E |
| 2024-12-11 | -1.93 |
| 2024-12-10 | -2.03 |
| 2024-12-09 | -2.11 |
| 2024-12-06 | -1.99 |
| 2024-12-05 | -1.81 |
| 2024-12-04 | -1.90 |
| 2024-12-03 | -1.93 |
| 2024-12-02 | -2.07 |
| 2024-11-29 | -2.06 |
| 2024-11-27 | -2.08 |
| 2024-11-26 | -1.98 |
| 2024-11-25 | -1.99 |
| 2024-11-22 | -1.99 |
| 2024-11-21 | -1.90 |
| 2024-11-20 | -2.00 |
| 2024-11-19 | -1.98 |
| 2024-11-18 | -2.11 |
| 2024-11-15 | -2.00 |
| 2024-11-14 | -2.31 |
| 2024-11-13 | -2.21 |
| 2024-11-12 | -2.18 |
| 2024-11-11 | -2.40 |
| 2024-11-08 | -2.32 |
| 2024-11-07 | -2.32 |
| 2024-11-06 | -1.96 |
| 2024-11-05 | -1.85 |
| 2024-11-04 | -1.82 |
| 2024-11-01 | -1.82 |
| 2024-10-31 | -1.78 |
| 2024-10-30 | -1.83 |
| 2024-10-29 | -1.88 |
| 2024-10-28 | -1.95 |
| 2024-10-25 | -1.94 |
| 2024-10-24 | -1.99 |
| 2024-10-23 | -2.02 |
| 2024-10-22 | -1.99 |
| 2024-10-21 | -2.15 |
| 2024-10-18 | -2.30 |
| 2024-10-17 | -2.20 |
| 2024-10-16 | -2.23 |
| 2024-10-15 | -2.14 |
| 2024-10-14 | -2.12 |
| 2024-10-11 | -2.05 |
| 2024-10-10 | -1.93 |
| 2024-10-09 | -1.92 |
| 2024-10-08 | -1.98 |
| 2024-10-07 | -1.98 |
| 2024-10-04 | -2.02 |
| 2024-10-03 | -1.94 |
| 2024-10-02 | -2.06 |